                                                                                                                                   I




                                  113TH CONGRESS
                                     1ST SESSION                          H. R. 820
                                  To amend the Federal Food, Drug, and Cosmetic Act to enhance the report-
                                    ing requirements pertaining to use of antimicrobial drugs in food animals.




                                                IN THE HOUSE OF REPRESENTATIVES
                                                             FEBRUARY 26, 2013
                                   Mr. WAXMAN (for himself and Ms. SLAUGHTER) introduced the following bill;
                                        which was referred to the Committee on Energy and Commerce




                                                                            A BILL
                                  To amend the Federal Food, Drug, and Cosmetic Act to
                                     enhance the reporting requirements pertaining to use
                                     of antimicrobial drugs in food animals.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,
                                    3     SECTION 1. SHORT TITLE.
                                    4              This Act may be cited as the ‘‘Delivering Anti-
                                    5 microbial Transparency in Animals Act of 2013’’.
                                    6     SEC. 2. FINDINGS.
                                    7              The Congress finds the following:
                                    8                        (1) Antimicrobials are of critical importance to




                                    9              public health and to the American economy.
                                                                                             2
                                    1                        (2) Use of antimicrobials, whether in human
                                    2              medicine or in agriculture, contributes to the devel-
                                    3              opment and spread of antimicrobial resistance.
                                    4                        (3) Data from the Food and Drug Administra-
                                    5              tion (FDA) indicate that approximately 80 percent
                                    6              of all antimicrobials sold in the United States, over
                                    7              29,000,000 pounds in 2009, were sold for use in
                                    8              food animals.
                                    9                        (4) A study published in September, 2012, in
                                  10               Proceedings of the National Academy of Sciences of
                                  11               the United States of America found that even low
                                  12               doses of antimicrobials in animal feed for short peri-
                                  13               ods of time increased the prevalence of the bacteria
                                  14               E. coli and the prevalence and diversity of anti-
                                  15               microbial resistance genes in bacteria in pigs.
                                  16                         (5) Public Law 110–316, the Animal Drug
                                  17               User Fee Amendments of 2008, requires producers
                                  18               of drugs used in food animals to provide specified in-
                                  19               formation annually to the FDA on the sales and in-
                                  20               dications for use of such drugs.
                                  21                         (6) A September 2011 study by the Govern-
                                  22               ment Accountability Office found that the data pro-
                                  23               vided to the FDA under the Animal Drug User Fee
                                  24               Amendments Act of 2008 lacked sufficient details




                                  25               necessary to analyze trends in antimicrobial resist-
                                              •HR 820 IH

                                                                                             3
                                    1              ance, such as information on actual drug use in spe-
                                    2              cific food-producing animal species.
                                    3     SEC. 3. PURPOSE.
                                    4              The purpose of this Act is to provide the Food and
                                    5 Drug Administration and the public with better informa-
                                    6 tion on the use of antimicrobial drugs in animals used for
                                    7 food to—
                                    8                        (1) enable public health officials and scientists
                                    9              to better understand and interpret trends and vari-
                                  10               ations in rates of microbial resistance to such anti-
                                  11               microbial drugs;
                                  12                         (2) improve the understanding of the relation-
                                  13               ship between antimicrobial drug use in animals used
                                  14               for food and antimicrobial drug resistance in mi-
                                  15               crobes in and on animals and humans; and
                                  16                         (3) identify interventions to prevent and control
                                  17               such antimicrobial drug resistance.
                                  18      SEC. 4. ENHANCED REPORTING REQUIREMENTS.

                                  19               (a) REPORTS.—Section 512(l) of the Federal Food,
                                  20 Drug, and Cosmetic Act (21 U.S.C. 360b(l)) is amended
                                  21 by striking paragraph (3) and inserting the following:
                                  22                         ‘‘(3)(A) In the case of each new animal drug
                                  23               described in paragraph (1) that contains an anti-
                                  24               microbial active ingredient, the sponsor of the drug




                                  25               shall submit an annual report to the Secretary on
                                              •HR 820 IH

                                                                                             4
                                    1              the amount of each antimicrobial active ingredient in
                                    2              the drug that is sold or distributed for use in food-
                                    3              producing animals, including information on any dis-
                                    4              tributor-labeled product.
                                    5                        ‘‘(B) Each report under this paragraph shall
                                    6              specify the amount of each antimicrobial active in-
                                    7              gredient—
                                    8                                 ‘‘(i) by container size, strength, and dosage
                                  109                        form;    ‘‘(ii) by quantities distributed to each State
                                  11                         domestically and by quantities exported; and
                                  12                                  ‘‘(iii) by dosage form, including (for each
                                  13                         dosage form) the known or estimated amounts
                                  14                         of the antimicrobial active ingredient sold or
                                  15                         distributed for use in each food-producing ani-
                                  16                         mal for which the new animal drug is approved,
                                  17                         including a description of the methods used to
                                  18                         determine or estimate the amounts.
                                  19                         ‘‘(4)(A) Subject to subparagraph (B), in the
                                  20               case of animal feed in final formulation bearing or
                                  21               containing a new animal drug for which reporting is
                                  22               required under paragraph (3), a live poultry dealer,
                                  23               swine contractor, or feed lot operator who purchases,
                                  24               contracts, or manufactures such feed shall submit to




                                  25               the Secretary an annual report that specifies, by
                                              •HR 820 IH

                                                                                             5
                                    1              food-producing animal for which the new animal
                                    2              drug is approved and, where applicable as deter-
                                    3              mined by the Secretary, by production class of such
                                    4              animal—
                                    5                                 ‘‘(i) the amount of each antimicrobial ac-
                                    6                        tive ingredient contained per kilogram of each
                                    7                        such feed sold or distributed for that animal
                                    8                        and, where applicable, production class;
                                    9                                 ‘‘(ii) the quantity of such feed sold or dis-
                                  10                         tributed for that animal and, where applicable,
                                  11                         production class; and
                                  12                                  ‘‘(iii) for each such feed sold or distributed
                                  13                         under a veterinary feed directive—
                                  14                                         ‘‘(I) the indications for which the feed
                                  15                                  was sold or distributed and the quantities
                                  16                                  of such feed that were sold or distributed
                                  17                                  per each such indication;
                                  18                                         ‘‘(II) the number of individuals of the
                                  19                                  food-producing animal and, where applica-
                                  20                                  ble, the production class to which the feed
                                  21                                  was intended; and
                                  22                                         ‘‘(III) the length of time over which
                                  23                                  the feed was intended to be provided to the
                                  24                                  animals and the dose of the active anti-





                                              •HR 820 IH

                                                                                             6
                                    1                                 microbial ingredient the animals were in-
                                    2                                 tended to receive.
                                    3                        ‘‘(B)(i) Subparagraph (A) does not apply to a
                                    4              live poultry dealer, swine contractor, or feed lot op-
                                    5              erator if the total value of the live animals owned,
                                    6              purchased, sold, contracted for, or otherwise con-
                                    7              trolled by the dealer, contractor, or operator, directly
                                    8              or through subsidiaries or affiliates, per year, does
                                  109              not exceed—      ‘‘(I) $10,000,000; or
                                  11                                  ‘‘(II) such other sum as the Secretary may
                                  12                         specify through regulation.
                                  13                         ‘‘(ii) The Secretary may specify through regula-
                                  14               tion alternative reporting requirements, including via
                                  15               pilot programs or based on the results of pilot pro-
                                  16               grams—
                                  17                                  ‘‘(I) to improve the accuracy of reports;
                                  18                                  ‘‘(II) to lessen the burden of reporting;
                                  19                                  ‘‘(III) to facilitate the Secretary’s ability to
                                  20                         provide public summaries of the reports; or
                                  21                                  ‘‘(IV) to improve the Secretary’s ability to
                                  22                         use the reports, or the public’s ability to use the
                                  23                         summaries under paragraph (5), to understand
                                  24                         the relationship between sales, distribution, and




                                  25                         end-use practices with respect to feed con-
                                              •HR 820 IH

                                                                                             7
                                    1                        taining new animal drugs described in para-
                                    2                        graph (1) and antimicrobial resistance trends in
                                    3                        microbes in animals, animal food products, and
                                    4                        humans.
                                    5                        ‘‘(5)(A) Each report under paragraph (3) or (4)
                                    6              shall—
                                    7                                 ‘‘(i) be submitted electronically not later
                                    8                        than March 31 each year;
                                    9                                 ‘‘(ii) cover the period of the preceding cal-
                                  10                         endar year;
                                  11                                  ‘‘(iii) include separate information for each
                                  12                         month of such calendar year; and
                                  13                                  ‘‘(iv) be in such format as the Secretary
                                  14                         may require.
                                  15                         ‘‘(B) In specifying a format under subpara-
                                  16               graph (A)(iv), the Secretary shall seek to ensure
                                  17               that such format enables the data reported to be in-
                                  18               tegrated or otherwise easily associated and compared
                                  19               with data from other Federal databases containing
                                  20               data on—
                                  21                                  ‘‘(i) drug sales for human use; and
                                  22                                  ‘‘(ii) rates of antimicrobial resistance in
                                  23                         bacteria in and on animals, animal food prod-
                                  24                         ucts, and people.





                                              •HR 820 IH

                                                                                             8
                                    1                        ‘‘(C) The Secretary may share information re-
                                    2              ported under paragraph (3) or (4) with the Anti-
                                    3              microbial Resistance Task Force established under
                                    4              section 319E of the Public Health Service Act.
                                    5                        ‘‘(D)(i) Not later than November 30 each year,
                                    6              the Secretary shall make publicly available sum-
                                    7              maries of the information reported under paragraphs
                                    8              (3) and (4).
                                    9                        ‘‘(ii) For each summary under clause (i), except
                                  10               as provided in clause (iii), the Secretary shall—
                                  11                                  ‘‘(I) report data by antimicrobial drug
                                  12                         class;
                                  13                                  ‘‘(II) for each such antimicrobial drug
                                  14                         class, specify—
                                  15                                         ‘‘(aa) the quantity of drugs sold or
                                  16                                  distributed per dosage form;
                                  17                                         ‘‘(bb) the percentage of drugs sold or
                                  18                                  distributed with labeled indications that
                                  19                                  fall within each of the following categories:
                                  20                                  growth promotion, feed efficiency, or other
                                  21                                  production purposes; disease prevention;
                                  22                                  disease control; and disease treatment;
                                  23                                         ‘‘(cc) the quantity of drugs sold or
                                  24                                  distributed per each of the following mar-





                                              •HR 820 IH

                                                                                             9
                                    1                                 keting categories: over-the-counter, pre-
                                    2                                 scription, and veterinary feed directive;
                                    3                                        ‘‘(dd) the quantity of drugs sold or
                                    4                                 distributed per State of sale or distribu-
                                    5                                 tion; and
                                    6                                        ‘‘(ee) the known or estimated quantity
                                    7                                 of drugs sold or distributed for each food-
                                    8                                 producing animal and, where feasible, pro-
                                    9                                 duction class of such animal; and
                                  10                                  ‘‘(III) for each feed sold or distributed
                                  11                         under a veterinary food directive for which re-
                                  12                         porting is required under paragraph (4), in-
                                  13                         clude the information reported pursuant to sub-
                                  14                         clauses (I), (II), and (III) of paragraph
                                  15                         (4)(A)(iii).
                                  16                         ‘‘(iii) For any antimicrobial drug class with
                                  17               fewer than 3 sponsors of approved new animal
                                  18               drugs, instead of reporting data under clause (ii),
                                  19               the Secretary shall for each such class—
                                  20                                  ‘‘(I) report data by category of importance
                                  21                         of the antimicrobial drugs within that class to
                                  22                         human medicine, as determined by the Sec-
                                  23                         retary; and
                                  24                                  ‘‘(II) to the extent feasible for each such




                                  25                         category, specify—
                                              •HR 820 IH

                                                                                         10
                                    1                                         ‘‘(aa) the quantity of drugs sold or
                                    2                                 distributed per dosage form;
                                    3                                         ‘‘(bb) the percentage of drugs sold or
                                    4                                 distributed with labeled indications that
                                    5                                 fall within each of the following categories:
                                    6                                 growth promotion, feed efficiency, or other
                                    7                                 production purposes; disease prevention;
                                    8                                 disease control; and disease treatment;
                                    9                                         ‘‘(cc) the quantity of drugs sold or
                                  10                                  distributed per each of the following mar-
                                  11                                  keting categories: over-the-counter, pre-
                                  12                                  scription, and veterinary feed directive; and
                                  13                                          ‘‘(dd) the quantity of drugs sold or
                                  14                                  distributed per State of sale or distribu-
                                  15                                  tion.
                                  16                         ‘‘(iv) In carrying out this subparagraph, the
                                  17               Secretary shall report data in a manner consistent
                                  18               with protecting both national security and confiden-
                                  19               tial business information.
                                  20                         ‘‘(E) In this paragraph, the terms ‘live poultry
                                  21               dealer’ and ‘swine contractor’ have the meanings
                                  22               given to those terms in section 2 of the Packers and
                                  23               Stockyards Act, 1921.’’.
                                  24               (b) RULE            OF     APPLICATION.—The amendment made




                                  25 by this section applies to reports under paragraphs (3)
                                              •HR 820 IH

                                                                                         11
                                    1 and (4) of section 512(l) of the Federal Food, Drug, and
                                    2 Cosmetic Act (21 U.S.C. 360b(l)) (as amended by sub-
                                    3 section (a)) that cover the period of calendar year 2014
                                    4 or any subsequent calendar year. The provisions of section
                                    5 512(l)(3) of such Act, as in effect the day before the date
                                    6 of enactment of this Act, apply to reports that cover the
                                    7 period of calendar year 2013.
                                    8     SEC. 5. ENHANCED COLLABORATION BETWEEN THE FOOD
                                    9                             AND DRUG ADMINISTRATION AND THE DE-
                                  10                              PARTMENT OF AGRICULTURE.
                                  11               The Secretary of Health and Human Services, acting
                                  12 through the Commissioner of Food and Drugs, shall in-
                                  13 crease collaboration and coordination with the Secretary
                                  14 of Agriculture to expand and coordinate the collection of
                                  15 data on the use of antimicrobial drugs in or on cattle,
                                  16 swine, chickens, turkeys, and such other food-producing
                                  17 animal species as agreed to by the Secretary of Health
                                  18 and Human Services and the Secretary of Agriculture, in-
                                  19 cluding by providing information to the Secretary of Agri-
                                  20 culture for use by—
                                  21                         (1) the Animal and Plant Health Inspection
                                  22               Service to help inform its collection of data through
                                  23               the National Animal Health Monitoring System; and





                                              •HR 820 IH

                                                                                         12
                                    1                        (2) the Economic Research Service to help in-
                                    2              form its collection of data through the Agricultural
                                    3              Resource Management Survey.
                                    4     SEC. 6. ACTION BY GOVERNMENT ACCOUNTABILITY OF-
                                    5                             FICE.
                                    6              (a) PUBLICATION                    OF     FINAL GUIDANCE.—Not later
                                    7 than 180 days after the date of enactment of this Act,
                                    8 the Secretary of Health and Human Services shall publish
                                    9 a final version of draft guidance #213, entitled ‘‘New Ani-
                                  10 mal Drugs and New Animal Drug Combination Products
                                  11 Administered in or on Medicated Feed or Drinking Water
                                  12 of Food-Producing Animals: Recommendations for Drug
                                  13 Sponsors for Voluntarily Aligning Product Use Conditions
                                  14 with GFI #209’’.
                                  15               (b) REPORT BY GAO.—
                                  16                         (1) IN      GENERAL.—Not                    later than 3 years after
                                  17               the publication of final guidance pursuant to sub-
                                  18               section (a), the Comptroller General of the United
                                  19               States shall commence a study to evaluate—
                                  20                                  (A) the voluntary approach used by the
                                  21                         Food and Drug Administration to eliminate in-
                                  22                         judicious use of antimicrobial drugs in food-pro-
                                  23                         ducing animals; and





                                              •HR 820 IH

                                                                                         13
                                    1                                 (B) the effectiveness of the data collection
                                    2                        activities conducted by the Food and Drug Ad-
                                    3                        ministration regarding antimicrobial resistance.
                                    4                        (2) REPORT.—Not later than 1 year after com-
                                    5              mencing the study required by paragraph (1), the
                                    6              Comptroller General of the United States shall sub-
                                    7              mit to the Committee on Health, Education, Labor,
                                    8              and Pensions of the Senate and the Committee on
                                    9              Energy and Commerce of the House of Representa-
                                  10               tives a report that describes the results of such
                                  11               study.
                                              •HR 820 IH                                   Æ
